Lv65
2240 积分 2022-01-27 加入
Safety and effectiveness of lusutrombopag in patients who have chronic liver disease with thrombocytopenia and undergoing invasive procedures: Real‐world post‐marketing surveillance in Japan
2天前
已完结
Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures: A Systematic Review and Meta-analysis
2天前
已完结
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
10天前
已完结
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC)
10天前
已完结
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer
11天前
已完结
Pharmacological Treatment of Parkinson Disease
17天前
已完结
Effects and Safety of Monoamine Oxidase-B Inhibitors for Early Parkinson’s Disease: A Network Meta-Analysis
17天前
已完结
Effects and Safety of Monoamine Oxidase-B Inhibitors for Early Parkinson’s Disease: A Network Meta-Analysis
17天前
已关闭
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
29天前
已完结
The evolving treatment landscape of metastatic urothelial cancer
29天前
已完结
皖公网安备34019202002308
